Author

Robert K. Brookland

Observed names: R Brookland, R K Brookland, R.K. Brookland, Robert Brookland

Institution: Chesapeake Urology Associates

Observed institutions: Fox Chase Cancer Center, Greater Baltimore Medical Center, Hospital of the University of Pennsylvania, Chesapeake Urology Associates, University of Pennsylvania

OpenAlex ID: A5022307245

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

2017 · Mahul B. Amin, Frederick L. Greene, et al. · CA A Cancer Journal for Clinicians · 6,526

Oxygen tension in human tumors: in vivo mapping using CT-guided probes.

1985 · R A Gatenby, L R Coia, et al. · Radiology · 102

The Postoperative Irradiation of Transitional Cell Carcinoma of the Renal Pelvis and Ureter

1985 · Robert K. Brookland, Melvyn P. Richter · The Journal of Urology · 53

Para-aortic nodal metastases in early cervical carcinoma: Long-term survival following extended-field radiotherapy

1984 · Stephen C. Rubin, Robert Brookland, et al. · Gynecologic Oncology · 42

Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes

1984 · Robert K. Brookland, Steven Rubin, et al. · International Journal of Radiation Oncology*Biology*Physics · 31

First interim results of the Radium-223 (Ra-223) reassure observational study in metastatic castration-resistant prostate cancer (mCRPC): Safety and baseline (BL) characteristics of U.S. patients (Pts) by prior/concomitant treatment (Tx).

2018 · Lauren Christine Harshman, A. Oliver Sartor, et al. · Journal of Clinical Oncology · 2

The American Joint Committee on Cancer turns 60

2019 · Frederick L. Greene, David R. Byrd, et al. · Cancer · 1

Long-term outcomes with radium-223 in metastatic castration resistant prostate cancer: US patient subset of the 10-year REASSURE global study.

2026 · Celestia S. Higano, Peter S. Conti, et al. · Journal of Clinical Oncology

Abstract C160: Baseline characteristics, safety, and efficacy of Radium-223 in metastatic castration resistant prostate cancer by race: Insights from the REASSURE US subset

2024 · Peter S. Conti, Oliver Sartor, et al. · Cancer Epidemiology Biomarkers & Prevention

Comparing patient profiles and treatment outcomes with radium-223 (223Ra) in real-world settings: Academic vs. community practice in the US—Insights from the REASSURE study.

2024 · Celestia S. Higano, Robert K. Brookland, et al. · Journal of Clinical Oncology

Safety outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223 following external beam radiation therapy: REASSURE US subset.

2024 · A. Oliver Sartor, Peter Conti, et al. · Journal of Clinical Oncology

Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology

2023 · Elliot A. Asare, Robert K. Brookland, et al. · Journal of the National Comprehensive Cancer Network

Treatment Patterns, Patient Characteristics, and Preliminary Safety in the Radium-223 (Ra-223) REASSURE Observational Study

2017 · S.H. Zimberg, T. Richardson, et al. · International Journal of Radiation Oncology*Biology*Physics

Definitive irradiation following breast-conserving surgery for early stage breast cancer.

1990 · R K Brookland, A L Blumberg · PubMed

Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes

1984 · Steven Rubin, Robert K. Brookland, et al. · International Journal of Radiation Oncology*Biology*Physics

Paraaortic nodal metastases in early cervical carcinoma: Long-term survival following extended field radiotherapy

1983 · Stephen C. Rubin, Robert Brookland, et al. · Gynecologic Oncology

Works count: 16

Citation count: 6,752

H-index: 5

I10-index: 5